bioAffinity Technologies
BIAFW
5 hedge funds and large institutions have $26.3K invested in bioAffinity Technologies in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0.03% more ownership
Funds ownership: 3.34% → 3.37% (+0.03%)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
81% less capital invested
Capital invested by funds: $137K → $26.3K (-$111K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.14K |
| 2 |
CS
Clear Street
New York
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$842 |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$507 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$60 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $18.6K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $2.35K | -$842 | -2,823 | -10% |
|
|
CS
3
Clear Street
New York
| $2.32K | +$30 | +100 | +0.4% |
|
|
WAM
4
Warberg Asset Management
Winnetka,
Illinois
| $2.09K | -$507 | -1,700 | -7% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $961 | +$3.14K | +10,525 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$60 | -285 | Closed |
|
BIAFW Hedge Fund Activity: Q3 2023 in Review
5 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q3 2023, worth a combined $26.3K — down 81% from $137K a quarter earlier.
Fund positioning in BIAFW was balanced in Q3 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.14K. The largest seller was Citadel Advisors, cutting an estimated $842.
- 5 institutional investors held bioAffinity Technologies (BIAFW) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $26.3K of bioAffinity Technologies stock for Q3 2023, down 81% quarter-over-quarter.
- 1 fund opened new bioAffinity Technologies positions in Q3 2023 and 1 closed out, a net change of 0 holders.
- The largest bioAffinity Technologies buyer in Q3 2023 was Susquehanna International Group, an estimated $3.14K added.
- The largest bioAffinity Technologies seller in Q3 2023 was Citadel Advisors, an estimated $842 sold.
Based on aggregated 13F filings for Q3 2023.